| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.6M | — | -8.0% |
| R&D Expense | $34.0M | — | -17.5% |
| SG&A Expense | $26.2M | — | +85.4% |
| Operating Income | -$34.6M | — | -25.8% |
| Pre-tax Income | -$52.8M | — | -34.5% |
| Income Tax | $40K | — | -9.1% |
| Net Income | -$52.9M | — | -34.5% |
| EPS (Basic) | -$1.84 | — | -43.8% |
| EPS (Diluted) | -$1.84 | — | -43.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $248.5M | +4.3% | +151.9% |
| Accounts Receivable | $25.7M | -23.9% | +44.0% |
| Current Assets | $316.1M | -9.7% | -12.9% |
| Total Assets | $329.7M | -9.5% | -21.9% |
| Current Liabilities | $41.7M | +8.0% | -5.3% |
| Stockholders' Equity | $12.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.9M | — | -142.2% |
| Capital Expenditures | $17K | — | -51.4% |
| Investing Cash Flow | $35.0M | — | +135.6% |
| Financing Cash Flow | $1.2M | — | +104.2% |
| Free Cash Flow | -$25.9M | — | -141.6% |
| -62.5% |